[Dissecting the pathways of tumour escape: " question of life and death?"]

Georgi Tchernev1, Pietro Nenoff

  • 1Department of Dermatology, Venereology and Dermatologic Surgery, Kirchheim, Germany. georgi_tchernev@yahoo.de <georgi_tchernev@yahoo.de>

Insights

Apoptotic pathways protect against cancer by eliminating harmful cells. Novel therapies like TW-37 show promise in supporting programmed cell death, but their clinical significance requires further critical evaluation.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Context:

  • Apoptotic pathways are crucial for eliminating potentially cancerous cells.
  • Dysregulation of cell proliferation, differentiation, and apoptosis is implicated in tumor development.
  • The study examines the progression of melanocytic nevi towards dysplastic or malignant cells.

Purpose:

  • To explore the role of apoptotic pathways in cancer prevention and tumor progression.
  • To investigate the link between signal-transduction pathways and the tumor-immune system interaction.
  • To evaluate the potential of novel therapeutic agents in inducing programmed cell death.

Summary:

  • Apoptotic pathways serve as a defense against cancer by removing aberrant cells.
  • Disruptions in cell signaling pathways are observed in tumor cells and their interaction with the immune system.
  • The article focuses on the evolution of melanocytic nevi into dysplastic or tumor cells.
  • Identifying single molecules as prognostic markers for cancer genesis is challenging.
  • Emerging therapies, including TW-37, ABT-737, and TAT-Bim, aim to enhance programmed cell death.

Impact:

  • Highlights the complex interplay between apoptosis, cell signaling, and cancer development.
  • Discusses the challenges in using single molecules for cancer prognosis.
  • Introduces novel therapeutic strategies targeting programmed cell death for potential cancer treatment.
  • Emphasizes the need for critical assessment of the clinical utility of these innovative therapies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...